vs
Apellis Pharmaceuticals, Inc.（APLS）与DigitalOcean Holdings, Inc.（DOCN）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.2倍（$242.4M vs $199.9M），DigitalOcean Holdings, Inc.净利率更高（10.6% vs -29.5%，领先40.1%），DigitalOcean Holdings, Inc.同比增速更快（18.3% vs -5.9%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $-14.3M），过去两年DigitalOcean Holdings, Inc.的营收复合增速更高（14.5% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
APLS vs DOCN — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $242.4M |
| 净利润 | $-59.0M | $25.7M |
| 毛利率 | — | 58.7% |
| 营业利润率 | -25.6% | 16.0% |
| 净利率 | -29.5% | 10.6% |
| 营收同比 | -5.9% | 18.3% |
| 净利润同比 | -62.2% | 40.5% |
| 每股收益（稀释后） | $-0.40 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $242.4M | ||
| Q3 25 | $458.6M | $229.6M | ||
| Q2 25 | $178.5M | $218.7M | ||
| Q1 25 | $166.8M | $210.7M | ||
| Q4 24 | $212.5M | $204.9M | ||
| Q3 24 | $196.8M | $198.5M | ||
| Q2 24 | $199.7M | $192.5M | ||
| Q1 24 | $172.3M | $184.7M |
| Q4 25 | $-59.0M | $25.7M | ||
| Q3 25 | $215.7M | $158.4M | ||
| Q2 25 | $-42.2M | $37.0M | ||
| Q1 25 | $-92.2M | $38.2M | ||
| Q4 24 | $-36.4M | $18.3M | ||
| Q3 24 | $-57.4M | $32.9M | ||
| Q2 24 | $-37.7M | $19.1M | ||
| Q1 24 | $-66.4M | $14.1M |
| Q4 25 | — | 58.7% | ||
| Q3 25 | — | 59.6% | ||
| Q2 25 | — | 59.9% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 60.2% | ||
| Q2 24 | — | 61.0% | ||
| Q1 24 | — | 60.7% |
| Q4 25 | -25.6% | 16.0% | ||
| Q3 25 | 48.7% | 19.6% | ||
| Q2 25 | -18.6% | 16.3% | ||
| Q1 25 | -50.0% | 17.9% | ||
| Q4 24 | -12.3% | 15.9% | ||
| Q3 24 | -24.0% | 12.4% | ||
| Q2 24 | -14.7% | 11.6% | ||
| Q1 24 | -36.0% | 6.2% |
| Q4 25 | -29.5% | 10.6% | ||
| Q3 25 | 47.0% | 69.0% | ||
| Q2 25 | -23.6% | 16.9% | ||
| Q1 25 | -55.3% | 18.1% | ||
| Q4 24 | -17.1% | 8.9% | ||
| Q3 24 | -29.2% | 16.6% | ||
| Q2 24 | -18.9% | 9.9% | ||
| Q1 24 | -38.5% | 7.7% |
| Q4 25 | $-0.40 | $0.23 | ||
| Q3 25 | $1.67 | $1.51 | ||
| Q2 25 | $-0.33 | $0.39 | ||
| Q1 25 | $-0.74 | $0.39 | ||
| Q4 24 | $-0.30 | $0.21 | ||
| Q3 24 | $-0.46 | $0.33 | ||
| Q2 24 | $-0.30 | $0.20 | ||
| Q1 24 | $-0.54 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $254.5M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $370.1M | $-28.7M |
| 总资产 | $1.1B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $254.5M | ||
| Q3 25 | $479.2M | $236.6M | ||
| Q2 25 | $370.0M | $387.7M | ||
| Q1 25 | $358.4M | $360.4M | ||
| Q4 24 | $411.3M | $428.4M | ||
| Q3 24 | $396.9M | $439.9M | ||
| Q2 24 | $360.1M | $443.1M | ||
| Q1 24 | $325.9M | $419.1M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
| Q4 25 | $370.1M | $-28.7M | ||
| Q3 25 | $401.2M | $-69.6M | ||
| Q2 25 | $156.3M | $-175.2M | ||
| Q1 25 | $164.2M | $-210.7M | ||
| Q4 24 | $228.5M | $-203.0M | ||
| Q3 24 | $237.1M | $-211.7M | ||
| Q2 24 | $264.3M | $-253.8M | ||
| Q1 24 | $266.7M | $-286.1M |
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $821.4M | $1.7B | ||
| Q1 25 | $807.3M | $1.6B | ||
| Q4 24 | $885.1M | $1.6B | ||
| Q3 24 | $901.9M | $1.5B | ||
| Q2 24 | $904.5M | $1.5B | ||
| Q1 24 | $831.9M | $1.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $57.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $31.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 12.8% |
| 资本支出强度资本支出/营收 | 0.1% | 10.8% |
| 现金转化率经营现金流/净利润 | — | 2.23× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $180.5M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $57.3M | ||
| Q3 25 | $108.5M | $95.8M | ||
| Q2 25 | $4.4M | $92.4M | ||
| Q1 25 | $-53.4M | $64.1M | ||
| Q4 24 | $19.4M | $71.3M | ||
| Q3 24 | $34.1M | $73.4M | ||
| Q2 24 | $-8.3M | $71.3M | ||
| Q1 24 | $-133.0M | $66.7M |
| Q4 25 | $-14.3M | $31.1M | ||
| Q3 25 | $108.3M | $88.0M | ||
| Q2 25 | $4.4M | $59.3M | ||
| Q1 25 | $-53.4M | $2.1M | ||
| Q4 24 | $19.3M | $26.1M | ||
| Q3 24 | — | $16.0M | ||
| Q2 24 | $-8.4M | $39.5M | ||
| Q1 24 | $-133.3M | $23.0M |
| Q4 25 | -7.1% | 12.8% | ||
| Q3 25 | 23.6% | 38.3% | ||
| Q2 25 | 2.5% | 27.1% | ||
| Q1 25 | -32.0% | 1.0% | ||
| Q4 24 | 9.1% | 12.7% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | -4.2% | 20.5% | ||
| Q1 24 | -77.3% | 12.5% |
| Q4 25 | 0.1% | 10.8% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.0% | 15.2% | ||
| Q1 25 | 0.0% | 29.4% | ||
| Q4 24 | 0.0% | 22.1% | ||
| Q3 24 | 0.0% | 28.9% | ||
| Q2 24 | 0.0% | 16.6% | ||
| Q1 24 | 0.2% | 23.6% |
| Q4 25 | — | 2.23× | ||
| Q3 25 | 0.50× | 0.60× | ||
| Q2 25 | — | 2.50× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | 2.23× | ||
| Q2 24 | — | 3.73× | ||
| Q1 24 | — | 4.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
